Patent details

301219 Product Name: teclistamab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301219
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3337824
Status:
SPC granted but not yet in force
Application number:
301219
Procedural language:
Dutch
First Applicant Residence Country:
Belgium (BE)

Marketing Authorization

Marketing Authorization Number:
EU/1/22/1675
Marketing Authorization Type:
EEA
Marketing Authorization Date:
24/08/2022
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
22/02/2023
First Marketing Authorization date:
24/08/2022
Grant date:
04/04/2023
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
23/02/2023
SPC/SPC Extension Expiration Date:
23/08/2037
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
26/04/2023
 
 

 

Name:
Janssen Biotech, Inc.
Address:
800/850 Ridgeview Drive, 19044, Horsham, PA, United States of America (US)

Historical Applicant/holder

From:
22/02/2023
To:
26/04/2023

 

Name:
Janssen Pharmaceutica NV
Address:
Turnhoutseweg 30, 2340 BEERSE, Belgium (BE)

Agent

Name:
ir. B.Ch. Ledeboer c.s
From:
22/02/2023
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
20/23
Publication date:
17/05/2023
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
SPC
Journal edition number:
14/23
Publication date:
05/04/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
09/23
Publication date:
01/03/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202300881A
Date Registered:
26/04/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. H.A. Witmans c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Janssen Biotech, Inc.
Address:
800/850 Ridgeview Drive, 19044, Horsham, PA, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/08/2036
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
04/04/2023 Outgoing Correspondence Decision grant 1 PDF /3/0/9/6/5/0800856903/docs/301219_0_539381l504a.pdf
04/04/2023 Certificate Certificate 1 PDF /3/0/9/6/5/0800856903/docs/301219_1_spcmedcertificate20230404094025213.pdf
23/02/2023 Outgoing Correspondence Confirmation receipt request 1 PDF /3/0/9/6/5/0800856903/docs/301219_3_532656l174.pdf
22/02/2023 SPC Documents Annex SPC 2 PDF /3/0/9/6/5/0800856903/docs/301219_2_supplprotectioncertificate20230223121612485.pdf
22/02/2023 SPC Documents Marketing Authorization SPC 4 PDF /3/0/9/6/5/0800856903/docs/301219_4_supplprotectioncertificate20230223113151699.pdf
22/02/2023 SPC Documents Summary of the characteristics of the product 25 PDF /3/0/9/6/5/0800856903/docs/301219_5_supplprotectioncertificate20230223121507417.pdf
22/02/2023 SPC Documents Annex SPC 11 PDF /3/0/9/6/5/0800856903/docs/301219_6_supplprotectioncertificate20230223121540608.pdf
22/02/2023 SPC Documents Annex SPC 11 PDF /3/0/9/6/5/0800856903/docs/301219_7_supplprotectioncertificate20230223122113114.pdf
22/02/2023 SPC Documents Annex SPC 3 PDF /3/0/9/6/5/0800856903/docs/301219_8_supplprotectioncertificate20230223112855982.pdf
22/02/2023 SPC Documents SPC Documents 25 PDF /3/0/9/6/5/0800856903/docs/301219_9_supplprotectioncertificate20230223113111468.pdf
22/02/2023 SPC Documents Annex SPC 8 PDF /3/0/9/6/5/0800856903/docs/301219_10_supplprotectioncertificate20230223113004772.pdf
22/02/2023 SPC Documents Annex SPC 2 PDF /3/0/9/6/5/0800856903/docs/301219_11_supplprotectioncertificate20230223112828826.pdf
22/02/2023 Application Form First filed application form 3 PDF /3/0/9/6/5/0800856903/docs/301219_12_applicationform20230223112152560.pdf
22/02/2023 SPC Documents SPC Documents 4 PDF /3/0/9/6/5/0800856903/docs/301219_13_supplprotectioncertificate20230223113407250.pdf
22/02/2023 SPC Documents Annex SPC 3 PDF /3/0/9/6/5/0800856903/docs/301219_14_supplprotectioncertificate20230223121436385.pdf
22/02/2023 SPC Documents Annex SPC 8 PDF /3/0/9/6/5/0800856903/docs/301219_15_supplprotectioncertificate20230223122150694.pdf
22/02/2023 SPC Documents Annex SPC 8 PDF /3/0/9/6/5/0800856903/docs/301219_16_supplprotectioncertificate20230223121716340.pdf